Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  August 2014  »
MonTueWedThuFriSatSun
 123
45678910
11121314151617
18192021222324
25262728293031

Friends
    Links


    Entry 1 of 3100
    Last Page | Next Page
    3/5/2010 - Saladax Biomedical announces closing of $8.4M Series C Preferred offering
    Posted in Medical News

    Saladax Biomedical, Inc. announced today the close of an $8.4 million Series C Preferred oblation led by Excel Venture government of Boston. participants act Golden Seeds LLC, Ben potbelly stove telecommunications Partners, and the Life chemistry Greenhouse of Central Pennsylvania, as well as a number of angel investors. The funding will be used to accelerate product progress and expand clinical support of Saladax’s MYCARE™ line of diagnostic tests, which measure blood levels of cancer and Central Nervous System (CNS) malady drugs, contingent upon physicians with guidance to personalize patient dosing for optimal efficacy.

    More: - The rest...

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio